Concepedia
Statistics
Publications
8
Citations
167
H-Index
Active since
2012
Affiliations
AstraZeneca (United Kingdom)(Current)
GlaxoSmithKline (United Kingdom)
Age UK
Cranfield University
Anglia Ruskin University
W. Stebbeds is an author at AstraZeneca (United Kingdom) specializing in signal transduction, molecular biology, and medicine.
Publications per year
2012–2024
Antifibrotic Synergy Between Phosphodiesterase Type 5 Inhibitors and Selective Oestrogen Receptor Modulators in Peyronie's Disease Models
Marcus M. Ilg, Marta Mateus, W. Stebbeds et al. · European Urology · 2018 · 46 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +15
Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes
Kavita Raniga, Aishah Nasir, Nguyen T.N. Vo et al. · Cell stem cell · 2024 · 33 citations · Full text
Engineering, Biotechnology, Cardiology +17
Understanding the Role of Adenosine Receptors in the Myofibroblast Transformation in Peyronie’s Disease
Marta Mateus, Marcus M. Ilg, W. Stebbeds et al. · The Journal of Sexual Medicine · 2018 · 23 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +16
Deriving waveform parameters from calcium transients in human iPSC-derived cardiomyocytes to predict cardiac activity with machine learning
Hongbin Yang, W. Stebbeds, Jo Francis et al. · Stem Cell Reports · 2022 · 18 citations · Full text
Engineering, Cardiology, Physiology +17
An In Silico Study of the Differential Effect of Oxidation on Two Biologically Relevant G-Quadruplexes: Possible Implications in Oncogene Expression
W. Stebbeds, Lee Larcombe · PLoS ONE · 2012 · 15 citations · Full text
Medicine, Genetics, Molecular Biology +13
1–5 of 8